Literature DB >> 23324571

Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain.

Manuel García Cenoz1, Víctor Martínez-Artola, Marcela Guevara, Carmen Ezpeleta, Aurelio Barricarte, Jesús Castilla.   

Abstract

Varicella vaccine effectiveness was evaluated in a case-control study in Navarre, Spain, in 2010-2012. The cases were 54 children aged 15 months to 10 years with a diagnosis of varicella confirmed by polymerase-chain-reaction. Each case was matched with eight controls by pediatric practice, district of residence and date of birth. The effectiveness was 87% (95% confidence interval: 60% to 97%) for one dose of vaccine and 97% (80% to 100%) for two doses. A single dose was 93% (34% to 100%) effective in the first year, which declined to 61% (95% CI: -64% to 94%) after the third year. In conclusion, varicella vaccine is highly effective in preventing confirmed cases, although this effect declines over time since the first dose. A second dose helps to reestablish very high levels of effectiveness and to reduce the risk of breakthrough varicella.

Entities:  

Keywords:  breakthrough varicella; vaccine effectiveness; varicella; varicella vaccine; varicella-zoster virus

Mesh:

Substances:

Year:  2013        PMID: 23324571      PMCID: PMC3899156          DOI: 10.4161/hv.23451

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  20 in total

1.  The effectiveness of the varicella vaccine in clinical practice.

Authors:  M Vázquez; P S LaRussa; A A Gershon; S P Steinberg; K Freudigman; E D Shapiro
Journal:  N Engl J Med       Date:  2001-03-29       Impact factor: 91.245

2.  [Vaccination schedule of the Spanish Association of Pediatrics: recommendations 2004].

Authors: 
Journal:  An Pediatr (Barc)       Date:  2004-05       Impact factor: 1.500

3.  A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China.

Authors:  Li Lu; Luodan Suo; Juan Li; Lijun Zhai; Qingxiu Zheng; Xinghuo Pang; Stephanie R Bialek; Chengbin Wang
Journal:  Vaccine       Date:  2012-06-09       Impact factor: 3.641

4.  Efficacy of high-titer live attenuated varicella vaccine in healthy young children.

Authors:  T Varis; T Vesikari
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

Review 5.  Varicella.

Authors:  Ulrich Heininger; Jane F Seward
Journal:  Lancet       Date:  2006-10-14       Impact factor: 79.321

6.  Live attenuated varicella virus vaccine. Efficacy trial in healthy children.

Authors:  R E Weibel; B J Neff; B J Kuter; H A Guess; C A Rothenberger; A J Fitzgerald; K A Connor; A A McLean; M R Hilleman; E B Buynak
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245

7.  Effectiveness over time of varicella vaccine.

Authors:  Marietta Vázquez; Philip S LaRussa; Anne A Gershon; Linda M Niccolai; Catherine E Muehlenbein; Sharon P Steinberg; Eugene D Shapiro
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

8.  Ten year follow-up of healthy children who received one or two injections of varicella vaccine.

Authors:  Barbara Kuter; Holly Matthews; Henry Shinefield; Steve Black; Penelope Dennehy; Barbara Watson; Keith Reisinger; Lee Lian Kim; Lisa Lupinacci; Jonathan Hartzel; Ivan Chan
Journal:  Pediatr Infect Dis J       Date:  2004-02       Impact factor: 2.129

9.  Loss of vaccine-induced immunity to varicella over time.

Authors:  Sandra S Chaves; Paul Gargiullo; John X Zhang; Rachel Civen; Dalya Guris; Laurene Mascola; Jane F Seward
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

10.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Mona Marin; Dalya Güris; Sandra S Chaves; Scott Schmid; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2007-06-22
View more
  12 in total

1.  An evaluation of voluntary 2-dose varicella vaccination coverage in New York City public schools.

Authors:  Margaret K Doll; Jennifer B Rosen; Stephanie R Bialek; Hiram Szeto; Christopher M Zimmerman
Journal:  Am J Public Health       Date:  2014-12-18       Impact factor: 9.308

2.  Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012.

Authors:  Silvio Tafuri; Francesca Fortunato; Maria Giovanna Cappelli; Vanessa Cozza; Angela Bechini; Paolo Bonanni; Domenico Martinelli; Rosa Prato
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

3.  Effectiveness and impact of a single-dose vaccine against chickenpox in the community of Madrid between 2001 and 2015.

Authors:  Pello Latasa; Angel Gil de Miguel; Maria Dolores Barranco Ordoñez; Inmaculada Rodero Garduño; Juan Carlos Sanz Moreno; María Ordobás Gavín; María Esteban Vasallo; Macarena Garrido-Estepa; Luis García-Comas
Journal:  Hum Vaccin Immunother       Date:  2018-06-22       Impact factor: 3.452

4.  Determinants of varicella breakthrough: results of a 2012 case control study.

Authors:  Silvio Tafuri; Rocco Guerra; Maria Giovanna Cappelli; Domenico Martinelli; Rosa Prato; Cinzia Germinario
Journal:  Hum Vaccin Immunother       Date:  2014-01-07       Impact factor: 3.452

5.  Epidemiology of varicella and effectiveness of varicella vaccine in Hangzhou, China, 2019.

Authors:  Yuyang Xu; Yan Liu; Xiaoping Zhang; Xuechao Zhang; Jian Du; Yuxin Cai; Jun Wang; Xinren Che; Wenwen Gu; Wei Jiang; Junfang Chen
Journal:  Hum Vaccin Immunother       Date:  2020-06-23       Impact factor: 3.452

Review 6.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

7.  Immunogenicity and safety of different schedules of 2-dose varicella vaccination in China.

Authors:  Xuan Deng; Wenqing Xu; Rui Yan; Haiping Chen; Wei Shen; Min Zhang; Tengjie Wu; Bin Xu; Hanqing He; Yanli Ma
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

8.  Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students.

Authors:  Carrie A Thomas; Thein Shwe; Dee Bixler; Maria del Rosario; Scott Grytdal; Chengbin Wang; Loretta E Haddy; Stephanie R Bialek
Journal:  Pediatr Infect Dis J       Date:  2014-11       Impact factor: 2.129

9.  Changes in epidemiological characteristics and sero-prevalence against the varicella zoster virus in school-age children after the introduction of a national immunization program in Japan.

Authors:  Yosuke Yasui; Toshikatsu Mitsui; Fujiyo Arima; Keiko Uchida; Mikako Inokuchi; Mitsuaki Tokumura; Tetsuo Nakayama
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

10.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.